J Hypertens:荟萃分析显示抑郁症或增高血压发病危险

2012-04-06 范伟伟 医学论坛网

  由中国吉林大学白求恩第一医院和中国医学科学院阜外心血管病医院的学者联合开展的一项荟萃分析表明,抑郁症可能是高血压的独立危险因素。在高血压预防和治疗过程中将抑郁症纳入考量范畴非常重要,但尚需进一步研究以排除其他致淆因素的影响。研究于近日在线发表于《高血压杂志》(J Hypertens.)。   长期以来抑郁症被认为与高血压相关,然而抑郁症是否为高血压发病的危险因素目前尚无定论。该研究旨在评估抑

  由中国吉林大学白求恩第一医院和中国医学科学院阜外心血管病医院的学者联合开展的一项荟萃分析表明,抑郁症可能是高血压的独立危险因素。在高血压预防和治疗过程中将抑郁症纳入考量范畴非常重要,但尚需进一步研究以排除其他致淆因素的影响。研究于近日在线发表于《高血压杂志》(J Hypertens.)。

  长期以来抑郁症被认为与高血压相关,然而抑郁症是否为高血压发病的危险因素目前尚无定论。该研究旨在评估抑郁症能否增加高血压的发病率。

  研究者检索了Pubmed、EMBASE、Cochrane和PsycINFO数据库中所有语言的相关文献。荟萃分析纳入了报告血压正常的健康个体中抑郁症和高血压发病相关性的前瞻性队列研究。被入选的研究在基线时具有至少一次的抑郁症状/疾病自我报告或访视评估。高血压被定义为访视时重复测量血压升高(收缩压>140mmHg和/或舒张压>90 mmHg),应用降压药物治疗,或自报及病历记录的高血压诊断。横断面研究或病例对照研究被排除在外。由两位作者独立进行数据处理。

  结果显示,在最初检索的75项研究全文中仅有9项研究符合入选标准,其中涉及22367例参与者,平均随访时间为9.6年。研究人员发现:抑郁症可增加高血压发病危险[经校正相对危险度(RR)为1.42;95%可信区间(CI)为1.09-1.86,P=0.009)],且该危险与随访时间长短(P=0.0002)和基线时抑郁症的患病率显著相关(P <0.001)。

原始文献:

 


 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
    2013-02-04 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
    2012-04-08 liuxiaona
  6. [GetPortalCommentsPageByObjectIdResponse(id=1836827, encodeId=53bf183682ee1, content=<a href='/topic/show?id=1f188e230c5' target=_blank style='color:#2F92EE;'>#荟萃分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87230, encryptionId=1f188e230c5, topicName=荟萃分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b79433, createdName=fangcong, createdTime=Sat Jan 12 16:57:00 CST 2013, time=2013-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1681233, encodeId=d08b168123388, content=<a href='/topic/show?id=366b8e2299e' target=_blank style='color:#2F92EE;'>#荟萃#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87229, encryptionId=366b8e2299e, topicName=荟萃)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Sun Oct 14 02:57:00 CST 2012, time=2012-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725410, encodeId=2bb81e25410b9, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Feb 04 01:57:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2038440, encodeId=60cb2038440a0, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Tue May 22 16:57:00 CST 2012, time=2012-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1561533, encodeId=daf91561533f2, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1567542, encodeId=5a68156e542fe, content=<a href='/topic/show?id=118142341b1' target=_blank style='color:#2F92EE;'>#增高#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42341, encryptionId=118142341b1, topicName=增高)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af9415191444, createdName=liuxiaona, createdTime=Sun Apr 08 13:57:00 CST 2012, time=2012-04-08, status=1, ipAttribution=)]
    2012-04-08 liuxiaona

相关资讯

EPCRC发布首部癌症姑息治疗抑郁症管理指南

  癌症患者在姑息治疗中发生抑郁很常见,为使临床医师有“据”可依地进行处理,欧洲姑息治疗研究协作组(EPCRC)在系统性回顾了现有循证医学证据并进行了德尔斐(Delphi)研究后,制定出欧洲第一部癌症姑息治疗抑郁症管理指南。相关内容参见《欧洲癌症杂志》 [Eur J Cancer 2011, 47(5): 702]。   姑息治疗中抑郁症的预

PLoS One:HDAC6与抑郁症相关

近日,日本研究人员发现脑部神经细胞内含量很高的一种蛋白质与抑郁症有关。如果阻碍这种蛋白质发挥作用,能获得与使用抗抑郁药物相同的效果。相关报告已刊登在美国科学杂志《科学公共图书馆—综合》PLoS One的网络版上。日本爱知县身心障碍者精神发育障碍研究所与名古屋市立大学研究人员发现,在大脑发育时,一种名为HDAC6的蛋白质会增多。而在产生血清素的神经细胞中,也含有很多这种蛋白质。血清素对调节不安等情绪

甲状旁腺切除术可改善抑郁症及心血管异常

原发性甲状旁腺机能亢进(PHP)患者伴有抑郁症或亚临床心血管异常正在成为新的甲状旁腺切除术适应证。PHP已不再局限于一种具有代谢性骨病、胃肠道功能紊乱和肾结石等典型临床表现的疾病,在常规进行血清钙测定的时代,多数患者并无症状,或报告情绪、认知和神经肌肉功能异常等非特异性症状。美国骨与矿物质研究协会年会上报告的研究提示,在PHP患者中,有临床意义的抑郁症患病率更高且更严重,并且亚临床心血管异常也更为

Mol.Psychiatry:美研究发现验血可能帮助诊断抑郁症

由美国麻省总医院(MGH)的研究人员等组成的团队报告称,某项分析九个生物标志物水平的检测可准确区分抑郁症患者与对照参与者,而没有显着假阳性结果。相关论文发表在《分子精神病学》(Molecular Psychiatry)杂志上。 “传统上,抑郁症与其他精神障碍的诊断基于患者报告的症状;但该过程的准确性变异非常大,往往取决于进行评估的临床医师的临床经验与资源,”本报告的第一与通讯作者——麻省总医院精

AFM:有伴随疾病的抑郁症患者亦可接受抗抑郁症治疗

德州大学西南医学中心的David W. Morris 博士等近日在《家庭医学年报》(Annals of Family Medicine)发表论文称,对有其他伴随疾病的重度抑郁症患者使用抗抑郁症治疗也是安全且有效的。作者通过二次分析发现,与没有伴随疾病的抑郁症患者相比,患有高血压、糖尿病、关节炎等3至4种伴随疾病的抑郁症患者的28周缓解率没有明显差别。 之前有研究称,伴随疾病会干扰抑郁症的治疗,患

PNAS:电惊厥疗法或可治疗抑郁症

3月19日,国际著名杂志PNAS在线刊登了国外研究人员的最新研究成果“Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder,”,文章中,研究者表示,电惊厥疗法可能因通过改变大脑连接进而治疗抑郁症。 一项研究报告说,电惊厥疗法(ECT)目前是治疗严重抑郁症的最有